RTW INVESTMENTS, LP Q1 2021 Filing
Filed May 14, 2021
Portfolio Value
$6.4B
Holdings
111
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (111 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RCKTRocket Pharmaceuticals Inc | 15,715,286 | $697.3B | 10885.32% | |
| 2 | SPYSPDR S&P 500 ETF TR | 946,255 | $375.0B | 5854.57% | |
| 3 | VCELVericel Corp | 4,517,570 | $251.0B | 3917.59% | |
| 4 | PTCTPTC Therapeutics Inc | 5,293,966 | $250.7B | 3913.19% | |
| 5 | ALNYAlnylam Pharmaceuticals Inc | 1,683,362 | $237.7B | 3710.32% | |
| 6 | MRTXEURMirati Therapeutics Inc | 1,333,232 | $228.4B | 3565.28% | |
| 7 | —Dicerna Pharmaceuticals Inc | 7,463,291 | $190.8B | 2979.13% | |
| 8 | ILMNIllumina Inc | 481,956 | $185.1B | 2889.59% | |
| 9 | NTRANatera Inc | 1,712,234 | $173.9B | 2714.12% | |
| 10 | DMTKQDermTech Inc | 3,118,665 | $158.4B | 2472.73% | |
| 11 | ESTAEstablishment Labs Hldgs Inc | 2,319,138 | $145.0B | 2263.84% | |
| 12 | STOKStoke Therapeutics Inc | 3,644,248 | $141.5B | 2209.62% | |
| 13 | 3M4Masimo Corp | 594,956 | $136.6B | 2133.05% | |
| 14 | TXG10x Genomics Inc | 711,515 | $128.8B | 2010.44% | |
| 15 | CERNCHFCerner Corp | 1,774,485 | $127.5B | 1991.18% | |
| 16 | AXNX*Axonics Modulation Technolog | 1,883,864 | $112.8B | 1761.31% | |
| 17 | QDELUSDQuidel Corp | 878,533 | $112.4B | 1754.53% | |
| 18 | ARVNArvinas Inc | 1,622,799 | $107.3B | 1674.54% | |
| 19 | GMEDGlobus Med Inc | 1,670,811 | $103.0B | 1608.54% | |
| 20 | IMVTImmunovant Inc | 6,356,743 | $102.0B | 1591.73% | |
| 21 | TNDMTandem Diabetes Care Inc | 1,139,230 | $100.5B | 1569.48% | |
| 22 | 5E7Iteos Therapeutics Inc | 2,762,791 | $94.4B | 1474.17% | |
| 23 | GHGuardant Health Inc | 609,774 | $93.1B | 1453.10% | |
| 24 | AXSMAxsome Therapeutics Inc | 1,616,497 | $91.5B | 1428.81% | |
| 25 | PTGXProtagonist Therapeutics Inc | 3,507,390 | $90.8B | 1418.12% | |
| 26 | RNAAvidity Biosciences Inc | 3,995,000 | $87.1B | 1360.20% | |
| 27 | TCE2Celldex Therapeutics Inc New | 3,908,947 | $80.5B | 1257.06% | |
| 28 | CCCCC4 Therapeutics Inc | 2,149,228 | $79.4B | 1240.09% | |
| 29 | TARSTarsus Pharmaceuticals Inc. | 2,463,601 | $79.1B | 1234.69% | |
| 30 | ADVMCHFAdverum Biotechnologies Inc | 7,348,976 | $72.5B | 1131.19% | |
| 31 | —Translate Bio Inc | 4,382,199 | $72.3B | 1128.08% | |
| 32 | MGNXMacroGenics Inc | 2,014,400 | $64.2B | 1001.58% | |
| 33 | IDYAIdeaya Biosciences Inc | 2,466,255 | $58.0B | 904.76% | |
| 34 | CSTLCastle Biosciences Inc | 799,009 | $54.7B | 853.92% | |
| 35 | RLMDRelmada Therapeutics Inc | 1,530,717 | $53.9B | 841.38% | |
| 36 | NSTGEURNanoString Technologies Inc | 804,029 | $52.8B | 824.77% | |
| 37 | AVDLAvadel Pharmaceuticals plc | 5,741,939 | $51.9B | 810.32% | |
| 38 | —Prometheus Biosciences Inc | 3,264,031 | $51.7B | 807.51% | |
| 39 | LUNGPulmonx Corp | 1,129,600 | $51.7B | 806.59% | |
| 40 | IMCRImmunocore Hldgs PLC | 1,245,532 | $50.1B | 782.77% | |
| 41 | —Athira Pharma Inc | 2,652,553 | $48.8B | 761.92% | |
| 42 | CYTKCytokinetics Inc | 2,000,000 | $46.5B | 726.22% | |
| 43 | PRQRProQR Thrapeutics N V | 6,424,078 | $42.5B | 662.89% | |
| 44 | OPHTEURIVERIC bio Inc | 6,722,624 | $41.5B | 648.57% | |
| 45 | —Curis Inc | 3,619,544 | $41.0B | 639.63% | |
| 46 | —Genetron Hldgs Ltd | 1,818,162 | $39.0B | 609.11% | |
| 47 | —Landos Biopharma Inc | 4,275,722 | $38.3B | 598.34% | |
| 48 | FULCFulcrum Therapeutics Inc | 3,205,291 | $37.8B | 589.44% | |
| 49 | AGENEURAgenus Inc | 13,777,244 | $37.5B | 585.01% | |
| 50 | OMGBPOutset Med Inc | 687,152 | $37.4B | 583.44% | |
| 51 | OYSTOyster Pt Pharma Inc | 1,861,209 | $34.0B | 531.13% | |
| 52 | APYXApyx Medical Corporation | 3,391,279 | $32.8B | 511.42% | |
| 53 | KURAKura Oncology Inc | 1,081,912 | $30.6B | 477.48% | |
| 54 | XGNExagen Inc | 1,626,365 | $28.5B | 444.30% | |
| 55 | JNJJohnson & Johnson | 170,542 | $28.0B | 437.56% | |
| 56 | MDXGMiMedx Group Inc | 2,700,320 | $27.8B | 434.19% | |
| 57 | MISTMilestone Pharmaceuticals In | 4,315,102 | $25.0B | 390.02% | |
| 58 | TREURTrillium Therapeutics Inc | 2,091,389 | $22.5B | 350.65% | |
| 59 | TELATela Bio Inc | 1,382,343 | $20.6B | 321.54% | |
| 60 | I9DNArbutus Biopharma Corp | 5,978,355 | $19.9B | 310.78% | |
| 61 | BLUBellus Health Inc New | 4,968,017 | $19.0B | 297.23% | |
| 62 | PMVPPmv Pharmaceuticals Inc | 484,133 | $15.9B | 248.57% | |
| 63 | IMUXImmunic Inc | 920,814 | $14.7B | 229.14% | |
| 64 | BWAYBrainsway Ltd | 1,602,181 | $14.5B | 225.86% | |
| 65 | RGNXRegenxbio Inc | 416,577 | $14.2B | 221.82% | |
| 66 | BLIUSDBerkeley Lts Inc | 257,546 | $12.9B | 201.96% | |
| 67 | CTMXCytomx Therapeutics Inc | 1,533,758 | $11.9B | 185.08% | |
| 68 | —Aslan Pharmaceuticals Ltd | 3,250,000 | $10.9B | 169.97% | |
| 69 | CLSDUSDClearside Biomedical Inc | 4,206,765 | $10.4B | 162.21% | |
| 70 | —La Jolla Pharmaceutical Co | 2,327,903 | $9.9B | 154.08% | |
| 71 | —Vincerx Pharma Inc | 500,000 | $9.7B | 150.65% | |
| 72 | INMDInmode Ltd | 124,999 | $9.0B | 141.22% | |
| 73 | ARGXargenx SE | 31,752 | $8.7B | 136.50% | |
| 74 | APVOAptevo Therapeutics Inc | 281,402 | $8.6B | 134.07% | |
| 75 | —Chardan Healthcr Acqstn 2 Co | 837,540 | $8.4B | 131.40% | |
| 76 | CNTBConnect Biopharma Holdings Ltd | 450,000 | $8.3B | 129.96% | |
| 77 | EPIEUREssa Pharma Inc | 283,692 | $8.2B | 128.65% | |
| 78 | SRRKScholar Rock Holding Corp | 161,612 | $8.2B | 127.81% | |
| 79 | MLTXHelix Acquisition Corp | 750,000 | $7.7B | 119.55% | |
| 80 | —Arya Sciences Acquisition Co | 500,000 | $6.9B | 107.56% | |
| 81 | CERE1EURCerevel Therapeutics Hldng I | 500,000 | $6.9B | 107.17% | |
| 82 | —Olink Hldg AB | 185,838 | $6.7B | 104.44% | |
| 83 | —BCTG Acquisition Corp | 600,000 | $6.7B | 104.16% | |
| 84 | —Lifesci Acquisition Ii Corp | 650,000 | $6.6B | 102.89% | |
| 85 | —Research Alliance Corp II | 637,000 | $6.5B | 101.92% | |
| 86 | —Bcls Acquisition Corp | 612,500 | $6.5B | 101.07% | |
| 87 | —Itamar Med Ltd | 268,609 | $6.4B | 100.43% | |
| 88 | AFIBAcutus Med Inc | 451,834 | $6.0B | 94.31% | |
| 89 | RCELAvita Medical Inc | 280,000 | $5.5B | 86.64% | |
| 90 | —Arya Sciences Acqu Corp IV | 500,000 | $5.2B | 81.74% | |
| 91 | —Therapeutics Acquisition Corp | 490,000 | $5.2B | 80.40% | |
| 92 | BOLT1EURBolt Biotherapeutics Inc | 150,000 | $4.9B | 77.07% | |
| 93 | IMTXImmatics N.V | 350,000 | $3.9B | 61.26% | |
| 94 | —5 01 Acquisition Corp | 392,000 | $3.9B | 60.88% | |
| 95 | —Chardan Healthcr Acqstn 2 Co | 350,000 | $3.7B | 57.48% | |
| 96 | PSNLPersonalis Inc | 127,501 | $3.1B | 48.99% | |
| 97 | NUVBNuvation Bio Inc | 300,000 | $3.1B | 48.94% | |
| 98 | —Medicus Sciences Acquisition | 300,000 | $3.0B | 46.13% | |
| 99 | BDSXBiodesix Inc | 125,000 | $2.5B | 39.64% | |
| 100 | MRVIMaravai Lifesciences Hldgs I | 70,000 | $2.5B | 38.95% |
Page 1 of 2Next